Holen Sie sich die Stockscreener-App
84.06
0.28%
-0.24
Handel nachbörslich:
84.06
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MET?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$84.30
Offen:
$84.37
24-Stunden-Volumen:
3.78M
Relative Volume:
1.02
Marktkapitalisierung:
$54.09B
Einnahmen:
$77.59B
Nettoeinkommen (Verlust:
$3.62B
KGV:
16.26
EPS:
5.1701
Netto-Cashflow:
$16.53B
1W Leistung:
+5.36%
1M Leistung:
+9.21%
6M Leistung:
+11.98%
1J Leistung:
+8.24%
1-Tages-Spanne:
$83.89
$85.29
1-Wochen-Bereich:
$79.47
$85.29
52-Wochen-Spanne:
$67.33
$85.29
Metlife Inc Stock (MET) Company Profile
Firmenname
Metlife Inc
Sektor
Branche
Telefon
212-578-5500
Adresse
200 PARK AVENUE, NEW YORK, NY
Compare MET vs MFC, AFL, PUK, PRU
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MET
Metlife Inc
|
84.06 | 54.24B | 77.59B | 3.62B | 16.53B | 5.1701 |
MFC
Manulife Financial Corp
|
38.53 | 65.15B | 44.31B | 4.69B | 20.94B | 2.5185 |
AFL
Aflac Inc
|
117.86 | 59.96B | 18.11B | 4.64B | 2.93B | 8.812 |
PUK
Prudential Plc Adr
|
30.47 | 39.17B | 27.81B | 4.12B | 1.87B | 3.07 |
PRU
Prudential Financial Inc
|
104.12 | 36.21B | 62.83B | 3.60B | 9.79B | 9.7297 |
Metlife Inc Stock (MET) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-12-16 | Eingeleitet | Mizuho | Outperform |
| 2025-09-19 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-09-16 | Eingeleitet | Wolfe Research | Outperform |
| 2025-01-23 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2024-10-09 | Eingeleitet | TD Cowen | Buy |
| 2024-09-05 | Eingeleitet | Barclays | Overweight |
| 2024-01-08 | Hochstufung | Goldman | Neutral → Buy |
| 2023-11-17 | Fortgesetzt | Barclays | Overweight |
| 2023-10-05 | Eingeleitet | Deutsche Bank | Hold |
| 2023-09-14 | Hochstufung | Jefferies | Hold → Buy |
| 2023-01-09 | Herabstufung | Goldman | Buy → Neutral |
| 2022-12-09 | Herabstufung | Jefferies | Buy → Hold |
| 2022-09-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-06-23 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-05-24 | Eingeleitet | Citigroup | Buy |
| 2022-01-26 | Eingeleitet | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-01-12 | Bestätigt | UBS | Buy |
| 2022-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-04-21 | Eingeleitet | UBS | Buy |
| 2021-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-17 | Eingeleitet | Barclays | Overweight |
| 2020-06-01 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-03-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-07-16 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-03-19 | Herabstufung | Sandler O'Neill | Buy → Hold |
| 2019-01-16 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-01-02 | Hochstufung | Sandler O'Neill | Hold → Buy |
| 2018-06-04 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-25 | Eingeleitet | Credit Suisse | Outperform |
| 2018-03-26 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-01-02 | Eingeleitet | Deutsche Bank | Hold |
| 2017-11-10 | Herabstufung | Sandler O'Neill | Buy → Hold |
| 2017-11-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-05-25 | Hochstufung | FBR & Co. | Mkt Perform → Outperform |
| 2017-03-06 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-01-26 | Eingeleitet | Citigroup | Sell |
| 2016-12-09 | Herabstufung | Standpoint Research | Buy → Hold |
Alle ansehen
Metlife Inc Aktie (MET) Neueste Nachrichten
MetLife: Time To Go Long The Common Shares And 6.35% Yielding Preferreds (NYSE:MET) - Seeking Alpha
MetLife Inc. Operating Earnings Rise 14% to $1.6 Billion - AOL.com
UBS (AMUB) issues MetLife‑linked auto‑call securities — 10.30% periodic coupon - Stock Titan
MetLife Inc. (NYSE: MET) Climbs to New 52-Week High - InsuranceNewsNet
MET Stock Chart | METLIFE INC (NYSE:MET) - ChartMill
MetLife stock (US59156R1086): Morgan Stanley lifts target to $93 - AD HOC NEWS
MetLife Inc. stock outperforms competitors on strong trading day - MarketWatch
MetLife Inc stock (US59156R1086): Morgan Stanley lifts target after Q1 momentum - AD HOC NEWS
Keefe, Bruyette & Woods Maintains MetLife (MET) Outperform Recommendation - MSN
Metlife stock hits 52-week high at 83.85 USD By Investing.com - Investing.com Nigeria
Metlife stock hits 52-week high at 83.85 USD - Investing.com
Morgan Stanley Downgrades MetLife(MET.US) to Hold Rating, Raises Target Price to $93 - Moomoo
Morgan Stanley Adjusts Price Target on MetLife to $93 From $89, Maintains Overweight Rating - marketscreener.com
MetLife Inc. stock (US59156R1086): Q1 2026 momentum and fresh analyst targets in focus - AD HOC NEWS
MET Stock Price, Quote & Chart | METLIFE INC (NYSE:MET) - ChartMill
MetLife (MET) Is Up 5.7% After Strong Q1 2026 Results And Capital Returns PushHas The Bull Case Changed? - simplywall.st
MetLife Q1 earnings call highlights - MSN
MetLife stock (US59156R1086): earnings update and dividend profile for US investors - AD HOC NEWS
MetLife stock (US59156R1086): first?quarter 2026 earnings momentum and dividend profile in focus - AD HOC NEWS
MetLife, Inc. Preferred Series A Floating Rate (MET/PA) - Minichart
MetLife and Global Citizen Launch “Footwork for Futures” Social Media Challenge to Help Expand Access to Education and Sports - 뉴스와이어
MetLife Reports Strong First-Quarter 2026 Financial Performance - TipRanks
MetLife Q1 earnings beat, aided by investment income growth, group benefits results - MSN
MetLife stock (US59156R1086): higher dividend and buyback keep income investors watching - AD HOC NEWS
MetLife stock (US59156R1086): earnings beat and analyst optimism keep the spotlight on the insurer - AD HOC NEWS
Can higher investment income help MetLife deliver a Q1 earnings beat? - MSN
Michel Khalaf: Lebanese-American Engineer, Alico Globe-Trotter, and President and CEO of MetLife - BBN Times
MetLife Inc stock (US59156R1086): earnings jump and fresh dividends keep cash story in focus - AD HOC NEWS
MetLife Q1 2026 Earnings: Revenue Beat, EPS Above Consensus, Operating Income MissesNews and Statistics - IndexBox
Will Strong Q1 Results And Capital Returns Shift MetLife's (MET) Long‑Term Investment Narrative? - Yahoo Finance
MetLife stock (US59156R1086): Q1 earnings and preferred dividends highlight steady cash generation - AD HOC NEWS
MetLife’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
METLIFE INC PRF SERIE 'A' FLOATING RATE USD25 To Go Ex-Dividend On May 29th, 2026 With 0.3119 USD Dividend Per Share - 富途牛牛
MetLife, Inc. (MET) Announces Quarterly Dividends on Preferred S - GuruFocus
MetLife Declares Second-Quarter 2026 Preferred Stock Dividends - TipRanks
MetLife (NYSE: MET) sets June 15, 2026 payout for preferred dividends - Stock Titan
MetLife Declares Second Quarter 2026 Preferred Stock Dividends - marketscreener.com
MetLife sets June 15 payout for three preferred stock dividends - Stock Titan
News | MetLife acquires Phoenix-area built-to-rent development for $45.85 million - CoStar
BMO Capital Adjusts Price Target on MetLife to $80 From $78, Maintains Market Perform Rating - marketscreener.com
MetLife (MET) reports earnings tomorrow: What to expect - MSN
MetLife Inc. (MET) files 13F showing $12.34M in holdings - Stock Titan
MetLife Valuation Debate Gains S&P 500 Index Attention - Kalkine Media
MetLife Completes Remarketing of Series C Senior Component Debentures - AOL.com
MetLife Inc stock (US59156R1086): Keefe Bruyette upgrades to Outperform - AD HOC NEWS
MetLife stock (US59156R1086): Analyst upgrades fuel recovery after Q1 earnings beat - AD HOC NEWS
MetLife stock (US59156R1086): JP Morgan raises price target after Q1 earnings - AD HOC NEWS
MetLife Inc. stock (US59156R1086): Leading US insurer with global reach - AD HOC NEWS
Keefe Bruyette & Woods Adjusts Price Target on MetLife to $98 From $87, Maintains Outperform Rating - marketscreener.com
JPMorgan Adjusts Price Target on MetLife to $96 From $95, Maintains Overweight Rating - Moomoo
MetLife says it does not owe Sun Life another cent - insurance-portal.ca
Finanzdaten der Metlife Inc-Aktie (MET)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):